The results from the two-way repeated-measures ANOVA (Table 4) indicated significant group × season interaction effects for both insulin (p = 0.020) and leptin (p < 0.001), suggesting differential seasonal responses between healthy participants and those with MS. Here, LEP is linked to myeloid sarcoma.